Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 26, 2019

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Head and Neck Cancer
Interventions
RADIATION

Stereotactic radiotherapy boost

"A stereotactic radiosurgery boost is given in two cases:~* Upfront boost-on the first day of overall treatment time (OTT) (to 6 days before beginning conventional radiotherapy).~* Direct boost-on Days 43-49 of OTT in relation to conventional radiotherapy to total dose (TD) 70 Gy, i.e., up to 6 days after a dose of 60 Gy.~Treatment is conducted as radiotherapy alone or radiochemotherapy based on cisplatin 100 mg/m2 or 40 mg/m2 in a 21-day or 7-day cycle, respectively~Patients who start the treatment from induction chemotherapy may have a chance to qualify for an upfront or direct boost, depending the evaluation of the response to systemic treatment~Prescribed doses of stereotactic boost are in the range of 10-18 Gy"

Trial Locations (1)

44-102

RECRUITING

1st Radiation and Clinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch,, Gliwice

All Listed Sponsors
lead

Maria Sklodowska-Curie National Research Institute of Oncology

OTHER